Association between insulin‐associated gene polymorphisms and new‐onset diabetes mellitus in statin‐treated patients
European Journal of Clinical Investigation · 2025
DOI: 10.1111/eci.14366 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Investigation, 2025. Verfasst von Minju Park und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, South Korea. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Diabetes Mellitus, Insulin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
While statins are effective at managing lipid levels, there is growing evidence for new‐onset diabetes mellitus (NODM). The insulin signalling pathway (ISP) inhibited by statins is one of the potential mechanisms; however, most studies have been limited to in vitro settings. Therefore, this study aimed to identify the genetic associations within the ISP‐related genes and NODM.
Methods
We performed a retrospective analysis of samples collected prospectively from February 2021 to May 2021. Among ISP‐related genes, we selected 11 candidate genes ( IGF1 , IGF2 , IGF1R , INSR , IRS1 , IRS2 , PIK3CA , PIK3CB , PIK3R1 , AKT1 and AKT2 ). An additional analysis was conducted comparing patients with DM prior to statin therapy and controls to determine whether the single nucleotide polymorphisms (SNPs) are specific to statin.
Results
A total of 602 patients were analysed, including 71 (11.8%) with statin‐induced NODM. After adjustment, IGF1R rs2715439, INSR rs1799817, INSR rs2059807 and PIK3R1 rs3730089 were found to be independently associated with NODM. In an additional analysis, all SNPs that demonstrated an association with statin‐induced NODM lost their significance in patients with DM prior to statin therapy.
Conclusion
This study revealed the ISP‐related genetic effects, specifically involving genes such as INSR , IGF1R and PIK3R1 , in the development of statin‐induced NODM. Our findings suggest a potential mechanism of statin‐induced NODM related to ISP‐related genetic variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, South Korea.
- Department of Neurology, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, South Korea.
- Department of Neurology, Ewha Womans University Seoul Hospital, Ewha Womans University College of Medicine, Seoul, South Korea.
- School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.
ORCID-Profile: Da Hoon Lee, Hye Sun Gwak
Förderung
- National Research Foundation of Korea
Zitieren
APA
Park, M., Kim, J. S., Park, Y. A., Lee, D. H., Choi, S. A., Chang, Y., Song, T. J., Gwak, H. S., & Yee, J. (2025). Association between insulin‐associated gene polymorphisms and new‐onset diabetes mellitus in statin‐treated patients. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14366
Vancouver
Park M, Kim JS, Park YA, Lee DH, Choi SA, Chang Y, et al. Association between insulin‐associated gene polymorphisms and new‐onset diabetes mellitus in statin‐treated patients. European Journal of Clinical Investigation. 2025. doi:10.1111/eci.14366
BibTeX
@article{Park2025,
author = {Park, Minju and Kim, Jung Sun and Park, Yoon-A and Lee, Da Hoon and Choi, Seo-A and Chang, Yoonkyung and Song, Tae-Jin and Gwak, Hye Sun and Yee, Jeong},
title = {Association between insulin‐associated gene polymorphisms and new‐onset diabetes mellitus in statin‐treated patients},
journal = {European Journal of Clinical Investigation},
year = {2025},
doi = {10.1111/eci.14366}
}
EUVIMED